Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

AbbVie Inc (NYSE:ABBV)

62.71
Delayed Data
As of May 27
 +0.81 / +1.31%
Today’s Change
45.45
Today|||52-Week Range
71.60
+5.86%
Year-to-Date
Biogen & AbbVie's Multiple Sclerosis Drug Gets FDA Nod
May 30 / Zacks.com - Paid Partner Content
'Mad Money' Lightning Round: CVS Is a Buy, Buy, Buy
May 24 / TheStreet.com - Paid Partner Content
3 Small Biotechs Make Some Noise on a Quiet Day
May 27 / TheStreet.com - Paid Partner Content
A Heavy Hitter Just Stepped Up to the Cystic Fibrosis Plate
May 20 / MotleyFool.com - Paid Partner Content
AbbVie's HUMIRA Gets EU Regulator's Positive Opinion To Treat Some Non-Infectious Uve...
May 27 / Benzinga - Paid Partner Content
Foreign investors in race for US yields
May 19 / FT.com - Paid Partner Content
Investors Eager for Gilead to Make Big Moves
May 26 / TheStreet.com - Paid Partner Content
Bear of the Day: AbbVie (ABBV)
May 18 / Zacks.com - Paid Partner Content
The Zacks Analyst Blog Highlights: XenoPort, Biodel and AbbVie
May 26 / Zacks.com - Paid Partner Content
PharMerica, AbbVie, Red Robin Gourmet Burgers, Habit Restaurants and Shake Shack high...
May 18 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: XenoPort Soars on Acquisition Deal, AbbVie Crohn's Disease Dru...
May 25 / Zacks.com - Paid Partner Content
New Strong Sell Stocks for May 17th
May 17 / Zacks.com - Paid Partner Content
AbbVie/Boehringer Report Crohn's Disease Drug Interim Data
May 25 / Zacks.com - Paid Partner Content
Who will bet against Chinese authorities: big questions for markets this week
May 15 / FT.com - Paid Partner Content
Billionaires Are Bailing on Gilead Sciences -- Should You, Too?
May 25 / MotleyFool.com - Paid Partner Content
Eurozone corporate bond deals pick up
May 09 / FT.com - Paid Partner Content
Remain Patient in This Sideways Market
May 24 / TheStreet.com - Paid Partner Content
Quintiles and IMS jump on the M&A bandwagon
May 04 / FT.com - Paid Partner Content
3 Stocks With Better Dividends Than Johnson & Johnson
May 24 / MotleyFool.com - Paid Partner Content